BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 22129889)

  • 1. Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.
    Boninsegna L; Panzuto F; Partelli S; Capelli P; Delle Fave G; Bettini R; Pederzoli P; Scarpa A; Falconi M
    Eur J Cancer; 2012 Jul; 48(11):1608-15. PubMed ID: 22129889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
    Ricci C; Casadei R; Taffurelli G; Buscemi S; D'Ambra M; Monari F; Santini D; Campana D; Tomassetti P; Minni F
    Pancreatology; 2013; 13(6):589-93. PubMed ID: 24280574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Hoffman JP
    Am Surg; 2004 Mar; 70(3):235-40; discussion 240. PubMed ID: 15055847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
    Parekh JR; Wang SC; Bergsland EK; Venook AP; Warren RS; Kim GE; Nakakura EK
    Pancreas; 2012 Aug; 41(6):840-4. PubMed ID: 22781907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
    Kazanjian KK; Reber HA; Hines OJ
    Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67.
    Genç CG; Falconi M; Partelli S; Muffatti F; van Eeden S; Doglioni C; Klümpen HJ; van Eijck CHJ; Nieveen van Dijkum EJM
    Ann Surg Oncol; 2018 Aug; 25(8):2467-2474. PubMed ID: 29789972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive pancreatic resection for primary pancreatic neuroendocrine tumor: is it justifiable?
    Teh SH; Deveney C; Sheppard BC
    Am J Surg; 2007 May; 193(5):610-3; discussion 613. PubMed ID: 17434366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
    Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
    Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
    J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of recurrence after resection of well-differentiated non-functioning pancreatic neuroendocrine tumors.
    Tan QQ; Wang X; Yang L; Chen YH; Tan CL; Zhu XM; Ke NW; Liu XB
    Medicine (Baltimore); 2020 Jun; 99(24):e20324. PubMed ID: 32541455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    J Am Coll Surg; 2006 Sep; 203(3):345-52. PubMed ID: 16931307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.